# The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.

> **NCT07433452** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Gabriella Gobbi** · enrollment: 50 (estimated)

## Conditions studied

- Healthy Participants
- Placebo - Control
- Psilocybin

## Interventions

- **DRUG:** Psilocybin (drug)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07433452
- **Lead sponsor:** Gabriella Gobbi
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2028-09-01
- **Final completion:** 2029-09-01
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-02-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07433452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07433452, "The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarkers.". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT07433452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*